Literature DB >> 30788414

Senescence controls prostatic neoplasia driven by Pten loss.

Maxime Parisotto1,2,3,4, Elise Grelet1,2,3,4, Rana El Bizri1,2,3,4, Daniel Metzger1,2,3,4.   

Abstract

We report that Pten (phosphatase and tensin homologue) ablation in prostatic epithelial cells of adult mice promotes cell proliferation to generate prostatic intraepithelial neoplasia. Moreover, our results demonstrate that proliferating Pten-deficient cells undergo replication stress and exhibit a DNA damage response, leading to cell senescence, as seen in oncogene-induced senescence.

Entities:  

Keywords:  DNA damage; mouse model; prostate cancer; replicative stress; senescence

Year:  2018        PMID: 30788414      PMCID: PMC6370383          DOI: 10.1080/23723556.2018.1511205

Source DB:  PubMed          Journal:  Mol Cell Oncol        ISSN: 2372-3556


  4 in total

Review 1.  Role of Senescence in Tumorigenesis and Anticancer Therapy.

Authors:  Ewelina Stoczynska-Fidelus; Marta Węgierska; Amelia Kierasińska; Damian Ciunowicz; Piotr Rieske
Journal:  J Oncol       Date:  2022-03-18       Impact factor: 4.375

Review 2.  Patterns of indolence in prostate cancer (Review).

Authors:  Minas Sakellakis; Laura Jacqueline Flores; Sumankalai Ramachandran
Journal:  Exp Ther Med       Date:  2022-03-28       Impact factor: 2.447

Review 3.  Interplay of Developmental Hippo-Notch Signaling Pathways with the DNA Damage Response in Prostate Cancer.

Authors:  Ioanna Mourkioti; Andriani Angelopoulou; Konstantinos Belogiannis; Nefeli Lagopati; Spyridon Potamianos; Efthymios Kyrodimos; Vassilis Gorgoulis; Angelos Papaspyropoulos
Journal:  Cells       Date:  2022-08-07       Impact factor: 7.666

Review 4.  The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer.

Authors:  Daniel J Turnham; Nicholas Bullock; Manisha S Dass; John N Staffurth; Helen B Pearson
Journal:  Cells       Date:  2020-10-22       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.